Please Scroll Down to See Forums Below
napsgear
genezapharmateuticals
domestic-supply
puritysourcelabs
UGL OZ
UGFREAK
napsgeargenezapharmateuticals domestic-supplypuritysourcelabsUGL OZUGFREAK

drug import laws

  • Thread starter Thread starter ryker77
  • Start date Start date
R

ryker77

Guest
House Ok's Plan to Import
Foreign Drugs.
The measure will let individuals order prescriptions from abroad without a prescription.*
©Los Angeles Times, Published July 12, 2001

WASHINGTON -- The House voted Wednesday to make it legal for Americans to purchase prescription drugs from foreign countries by mail order, a step that will lead to significant savings for older Americans who use the most prescriptions.
Thousands of Americans from California and Arizona now travel to Mexico, while residents of some northern border states, including Minnesota and Vermont, go to Canada for medicine.
Many drugs sold in the United States are far less expensive in foreign countries where governments impose price restrictions.
The measure easily passed the House by a vote of 324-101. Republican Reps. Michael Bilirakis of Tarpon Springs and Ric Keller of Orlando were the only members of the Florida delegation to vote against the measure.
Passage of the House bill underscores the growing importance of prescription drug costs as a political issue.
President Bush will offer his proposals today for Medicare reform, highlighted by a call for Medicare's 35-million beneficiaries to participate in discount purchasing programs when they buy prescription drugs.
"The president is very troubled about the price of prescription drugs and the lack of access that senior citizens have to prescription drugs," Ari Fleischer, the White House press secretary, said Wednesday.
The White House hopes to create a clearinghouse that will enable seniors who do not have access to discount cards to enroll with companies -- called pharmacy benefit managers -- that buy prescription drugs on behalf of insurance companies and health plans.
Fleischer, at his daily White House briefing, said the president's discount-card proposal is "very important -- even before Medicare reform can be enacted -- to help senior citizens to get the best prices possible so that the cost of prescription drugs can be lowered."
The potential for even deeper savings for consumers could come from the House-approved measure allowing imports by mail.
Rep. Gil Gutknecht, R-Minn., sponsor of the measure, cited an example in which a constituent using a special ointment for a skin problem paid $130 for a tube in the United States but on a trip to Ireland bought the same medication for $46.
"The bottom line is if you are wealthy enough to travel to Europe twice a year, you can bring back all the drugs you need for the year," he said. "But if you are a senior living on a fixed income, you pay the full price.
Earlier, the House rejected an amendment by Rep. Bernard Sanders, I-Vt., that would have allowed companies -- distributors and marketers -- to import pharmaceuticals for sale to U.S. consumers. Sanders said he was pleased by the final approval of Gutknecht's measure, calling it a "solid victory" in the quest for lower pharmaceutical prices.
A second amendment, approved on a voice vote, would give the FDA $1-million to check patent claims by pharmaceutical companies trying to delay approval of generic versions of their drugs.
The drug re-importation amendment passed Wednesday applies only to individuals, allowing the freedom to order drugs.
- Information from the New York Times and Associated Press was included in this report.
"The House voted Wednesday to make it legal for Americans to purchase prescription drugs from foreign countries by mail order, a step that will lead to significant savings for older Americans who use the most prescriptions.




By ROBERT PEAR, December 27, 2000 *

The Congressional Bills were unanimously passed by both the House and Senate this summer. The spirit of the bill was to somehow or other create opportunity for those who can not afford their prescription medications here in the USA an alternative, by giving them more facility to purchase foreign equivalents. In an article released today by the New York Times News Service (see below). The Administration took special care to mention the proposed legislation is not meant to discourage personal import of meds in 90 day supply for consumers. And essentially announces to all those who may not know as much, that such facility exists. More importantly this acknowledgement by Congressional leaders of the need for such alternatives has now been squarely placed in public view, removing the stigma long associated with personal import of meds for medical need.
Quote: "Individuals can still buy drugs from abroad. Scores of consumers cross the border and buy medications in Canada or Mexico. Also, growing numbers of consumers buy drugs from foreign countries. Federal officials have expressed concerns about both types of purchases, but they say that they generally do not challenge consumers importing small quantities of prescription drugs for personal use."
Senator Byron L. Dorgan was an author of the drug-import plan.







The Associated Press *
WASHINGTON, Dec. 26, 2000

At a presidential debate on Oct. 17, Mr. Bush said the drug-import program "makes sense" as a way to help people buy medicines at affordable prices. But advisers to Mr. Bush said today that he would also consider other ways to moderate spending on prescription drugs, which has grown rapidly in recent years.
The drug-import program was included in the annual spending bill for the Agriculture Department and the Food and Drug Administration. President Clinton supported a version of the drug-import program approved by the Senate on July 19 by a vote of 74 to 21. "I urge you to send me the Senate legislation," Mr. Clinton said in a letter to Congressional leaders in late September.
The bill was revised in negotiations between the House and the Senate. When Mr. Clinton signed it on Oct. 28. Under the law, drug makers could not block the sale or distribution of imported drugs in the United States. House Republican leaders, taking political heat over the high cost of prescription drugs, embraced the import scheme six weeks before Election Day. The purpose of the measure was to help Americans gain access to prescription drugs at the lower prices charged in foreign countries that regulate drug prices.
Senator Byron L. Dorgan, Democrat of North Dakota and an author of the legislation creating the drug- import program, has taken constituents to Canada to buy low-price prescription drugs.
Representative Bernard Sanders, independent of Vermont, led efforts to allow more drug imports, saying they could reduce drug costs in the United States by 30 percent to 50 percent.
Individuals can still buy drugs from abroad. Scores of consumers cross the border and buy medications in Canada or Mexico. Also, growing numbers of consumers buy drugs from foreign countries through the mail. Federal officials have expressed concerns about both types of purchases, but they say that they generally do not challenge consumers importing small quantities of prescription drugs for personal use.
Drug companies say they now have virtually complete control over the custody of prescription drugs, from the factory floor to the retail pharmacy.
In her letter, Dr. Shalala took a jab at Mr. Bush and Republicans in Congress.
Allowing drug imports, she said, can never be a substitute for providing drug benefits to the elderly as an integral part of Medicare, nor is the solution a prescription drug program run by the states to help people with low incomes.
Mr. Bush has proposed such a program, to provide "an immediate helping hand" to the elderly.






HOUSE VOTES TO PROTECT PERSONAL PRESCRIPTION MAIL ORDER
From Foreign Countries.*
What follows is part of an article published in 'The Washington Post', Tuesday, July 11, 2000.
"House Blocks Drug Import Curbs"
Amid growing public resentment of high prescription drug prices, the House voted overwhelmingly yesterday to prevent the government from discouraging the purchasing of drugs in Canada or other countries where the medicines are cheaper....The FDA sometimes sends warning letters to those caught doing it.
The [Food and Drug Admin] gives its employees discretion to permit import of drugs that violate its restrictions so long as they are intended for personal use.
The House approved 363 to 12, an amendment to an FDA appropriations bill that would prevent the agency from enforcing the importation ban.... A second amendment, approved 370 to 12, would bar the agency from sending warning letters."
When this is actually signed into law it may affect the way you do business as it effectively removes most import restrictions as long as the drugs are "intended for personal use."





Senate Approves Bill to Legalize Import Of Prescription Drugs From Foreign Countries.*
Senate OK's Prescription Imports:
By Janelle Carter
Associated Press Writer
Wednesday, July 19, 2000; 7:18 p.m. EDT
WASHINGTON –– The Senate agreed Wednesday to lift a ban on importing prescription drugs into the United States from foreign countries, responding to critics who have complained that Americans are being gouged by drug prices.
The measure, which passed 74-21, was attached to the agriculture spending bill currently being debated in the Senate. The debate centers on complaints that Americans are paying more for drugs available at a cheaper cost in some other countries.
"Why are we charged so much more for the identical drug?" said Sen. Byron Dorgan, D-N.D. and one of the sponsors of the measure. "If someone else is paying half price or a third of the price than is being charged to the American consumer ... why can't the American consumer have access to those drugs in a global economy?"
Dorgan said the measure will "force the industry to re-price their drugs in this country."
The bill also would bar the FDA from discouraging Americans from buying prescription drugs in Canada and other foreign countries. Technically, it's illegal to import prescription drugs that were originally made in the United States, and the Food and Drug Administration sometimes sends warning letters to people caught doing it.
The House has already passed similar measures. One House provision would prohibit the Food and Drug Administration from enforcing import bans. The other House provision would allow Americans to legally bring prescription drugs across the border from Canada and Mexico.
The debate has drawn heavy opposition from the pharmaceutical industry, which has taken several full-page newspaper ads in recent days urging Americans to call Congress.






SANDERS ORGANIZES TRIP TO CANADA TO HELP SENIORS BUY PRESCRIPTION DRUGS:*
FOR IMMEDIATE RELEASE: FEBRUARY 16, 2000
New study shows pharmaceutical industry cashing in on tax loopholes while fleecing American seniors
BURLINGTON, VT - Congressman Bernard Sanders (I-VT) today announced plans for a February 18th bus trip from Burlington to Montreal to help seniors purchase prescription drugs at affordable prices. Currently, U.S. law prohibits American pharmacists, wholesalers and distributors from purchasing prescription drugs in other countries such as Canada, where pharmaceutical prices are much more affordable. Sanders, who led a similar trip in July 1999, said he hopes the trip will illustrate the need for Congress to act on the bipartisan International Prescription Drug Parity Act that he co-authored and which is co-sponsored by 53 Members of Congress.
Sanders said, "There is no rational reason why the same exact drug, often manufactured by an American company in the United States, should be sold in Canada and other countries for a fraction of the price that it is sold here. Last year alone, while Americans paid the highest drug prices in the world, the 10 largest pharmaceutical companies in the U.S. reaped a 26% increase in their profits - an average of $2.5 billion each. At the same time, the pharmaceutical industry spent more than any other industry on lobbying and campaign contributions in order to protect their ability to fleece American consumers. We have now reached a crisis situation where seniors and the chronically ill can no longer afford their medications. Congress must act immediately to take on the pharmaceutical industry and protect the American consumer.
According to a new Congressional Research Service study, the pharmaceutical industry receives the largest tax breaks of any sector of the American economy. In 1996, for example, the industry was able to use various loopholes to avoid paying more than $3.8 billion. Since that time, the industry has averaged 17 percent profits, as compared to 5 percent for all other industries. At the same time the industry is benefiting from these tax loopholes, a GAO study requested by Sanders’ showed that pharmaceutical companies charge Americans the highest prices in the world for prescription drugs. According to the study, the average drug that sells for $1 in the United States would sell for 71 cents in Germany, 68 cents in Sweden, 64 cents in Canada and 51 cents in Italy. For Vermont, the study showed that seniors pay on average 81 percent more than Canadians for the 10 most widely used prescription drugs.
Sanders continued, "It is an absolute outrage that the taxpayers subsidize the pharmaceutical industry with egregious tax loopholes while the industry fleeces our seniors. My hope is that trips like this will show Congress that it is time to stop listening to the millions of dollars the pharmaceutical industry spends on campaign contributions and start listening to the millions of seniors who desperately need prescription drug relief. Though I am delighted that this trip will enable some Vermonters to obtain their medications at a fair price, this is clearly not the long-term answer to the prescription drug affordability crisis that Americans face. Our citizens should not have to go to another country to purchase affordable prescription drugs. They should be able to purchase their prescription drugs locally, at a fair price, under the supervision of their own pharmacists."
The trip from Burlington, Vermont to Montreal, Canada is being organized jointly by Sanders, the American Association of Retired People (AARP), the Champlain Valley Agency on Aging and the Champlain Senior Center. The trip will include a visit to a doctor to receive the prescription necessary to purchase the medications.

(Back To Top)





*The articles above have been edited for brevity.
 
The FDA, which estimates 2 million packages containing drugs — some approved, some not — enter the United States each year, fears people will be hurt by drugs that don't fall under its jurisdiction.
 
Personal Prescription Drug Import Fairness Act (Introduced in Senate)

S 1229 IS


107th CONGRESS

1st Session

S. 1229
To amend the Federal Food, Drug, and Cosmetic Act to permit individuals to import prescription drugs in limited circumstances.


IN THE SENATE OF THE UNITED STATES

July 24, 2001
Mr. WELLSTONE (for himself and Ms. STABENOW) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions



--------------------------------------------------------------------------------


A BILL
To amend the Federal Food, Drug, and Cosmetic Act to permit individuals to import prescription drugs in limited circumstances.


Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the `Personal Prescription Drug Import Fairness Act'.

SEC. 2. IMPORTATION OF PRESCRIPTION DRUGS BY INDIVIDUALS.

(a) IN GENERAL- Chapter VIII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381 et seq.) is amended by adding at the end the following:

`SEC. 805. IMPORTATION OF PRESCRIPTION DRUGS BY INDIVIDUALS.

`(a) DEFINITIONS- In this section:

`(1) IMPORT FORM- The term `import form' means a form prescribed by the Secretary, in consultation with the Secretary of the Treasury, that discloses--

`(A) the name, address, and telephone number of an individual who imports a prescription drug;

`(B) the name, address, and telephone number of the pharmacy or other entity that dispensed the prescription drug to the individual or ships the prescription drug to the individual in the United States;

`(C)(i) the name, address, and telephone number of the health care practitioner licensed to prescribe drugs in the United States who is responsible for the individual's treatment with the prescription drug; or

`(ii) evidence that the prescription drug is for the continuation of treatment begun outside the United States;

`(D) the location of the establishment that manufactured the prescription drug, to the extent known; and

`(E) such other information as the Secretary may require.

`(2) PRESCRIPTION DRUG- The term `prescription drug' means a drug subject to section 503(b), other than a controlled substance (as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or a biological product (as defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))).

`(b) REGULATIONS- The Secretary, after consultation with the United States Trade Representative and the Commissioner of Customs, shall promulgate regulations permitting individuals to import into the United States in personal baggage or by mail (or by other approved delivery service) a prescription drug that--

`(1) is imported for personal use by an individual, not for resale, at intervals of not less than approximately 90 days in quantities that do not exceed a 90-day supply;

`(2) is imported from a country, union, or economic area referred to in section 802(b)(1)(A) and is a legally dispensed drug in that country, union, or economic area;

`(3) is a prescription drug approved by the Secretary under chapter V;

`(4) is in the form of a final finished dosage that was manufactured in an establishment registered under section 510;

`(5) is accompanied by an import form; and

`(6) is imported under such other conditions as the Secretary determines to be necessary to ensure public safety.

`(c) RECORDS- The Secretary shall collect, and maintain for a period of time that the Secretary determines to be necessary, records of imports of prescription drugs under this section.

`(d) LIST OF DRUGS MANUFACTURED OUTSIDE THE UNITED STATES-

`(1) IN GENERAL- The Secretary shall maintain and make readily available to the public a list of drugs approved under chapter V that--

`(A) are manufactured in establishments outside the United States that are registered under section 510; or

`(B) are manufactured in establishments inside the United States that are registered under section 510 and are exported to a country, union, or economic area referred to in section 802(b)(1)(A).

`(2) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this subsection $1,000,000.'.

(b) CONFORMING AMENDMENT- Section 801(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 821(d)(1)) is amended by striking `section 804' and inserting `sections 804 and 805'.
 
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to permit individuals to import prescription drugs in limited circumstances.


Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the `Personal Prescription Drug Import Fairness Act'.

SEC. 2. IMPORTATION OF PRESCRIPTION DRUGS BY INDIVIDUALS.

(a) IN GENERAL- Chapter VIII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381 et seq.) is amended by adding at the end the following:

`SEC. 805. IMPORTATION OF PRESCRIPTION DRUGS BY INDIVIDUALS.

`(a) DEFINITIONS- In this section:

`(1) IMPORT FORM- The term `import form' means a form prescribed by the Secretary, in consultation with the Secretary of the Treasury, that discloses--

`(A) the name, address, and telephone number of an individual who imports a prescription drug;

`(B) the name, address, and telephone number of the pharmacy or other entity that dispensed the prescription drug to the individual or ships the prescription drug to the individual in the United States;

`(C)(i) the name, address, and telephone number of the health care practitioner licensed to prescribe drugs in the United States who is responsible for the individual's treatment with the prescription drug; or

`(ii) evidence that the prescription drug is for the continuation of treatment begun outside the United States;

`(D) the location of the establishment that manufactured the prescription drug, to the extent known; and

`(E) such other information as the Secretary may require.

`(2) PRESCRIPTION DRUG- The term `prescription drug' means a drug subject to section 503(b), other than a controlled substance (as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or a biological product (as defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))).

`(b) REGULATIONS- The Secretary, after consultation with the United States Trade Representative and the Commissioner of Customs, shall promulgate regulations permitting individuals to import into the United States in personal baggage or by mail (or by other approved delivery service) a prescription drug that--

`(1) is imported for personal use by an individual, not for resale, at intervals of not less than approximately 90 days in quantities that do not exceed a 90-day supply;

`(2) is imported from a country, union, or economic area referred to in section 802(b)(1)(A) and is a legally dispensed drug in that country, union, or economic area;

`(3) is a prescription drug approved by the Secretary under chapter V;

`(4) is in the form of a final finished dosage that was manufactured in an establishment registered under section 510;

`(5) is accompanied by an import form; and

`(6) is imported under such other conditions as the Secretary determines to be necessary to ensure public safety.

`(c) RECORDS- The Secretary shall collect, and maintain for a period of time that the Secretary determines to be necessary, records of imports of prescription drugs under this section.

`(d) LIST OF DRUGS MANUFACTURED OUTSIDE THE UNITED STATES-

`(1) IN GENERAL- The Secretary shall maintain and make readily available to the public a list of drugs approved under chapter V that--

`(A) are manufactured in establishments outside the United States that are registered under section 510; or

`(B) are manufactured in establishments inside the United States that are registered under section 510 and are exported to a country, union, or economic area referred to in section 802(b)(1)(A).

`(2) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this subsection $1,000,000.'.

(b) CONFORMING AMENDMENT- Section 801(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 821(d)(1)) is amended by striking `section 804' and inserting `sections 804 and 805'.
 
Some things you should know:

The person for whom the prescription is written must be the one that carries the medicine over the border. In other words, prescriptions cannot be filled for friends or family members.

When crossing the border, simply inform the border guards that you are visiting (or have visited) your physician, and that you have filled your prescriptions. Only a 90-day supply of the medicine can be carried over the border at a time. It is also important to have picture identification when crossing the border.

When you are ready to make the trip to Canada, refer to the list on the following pages to determine which doctor is the closest or most convenient for you. It is important that an appointment be made in advance to see the doctor.

If you choose to order your prescriptions through the Internet, be sure that the pharmacy you are using has a doctor that examines your medical records and has contact information for your US doctor. Also, inform your U.S. doctor that you are ordering from Canada so he/she may call to ask questions if necessary to ensure the right prescriptions. Do not order from a pharmacy/doctor in Canada that refuses to answer questions from your US doctor.

Prior to seeing the Canadian physician or ordering from a pharmacy through the Internet, be sure that you obtain the following from your current doctor in the US:

A brief written summary of health conditions, including any recent surgeries and any allergies to foods or medications.
Written prescriptions of the medicine(s) you are taking.

The exams and prescription rewriting process takes between 15 and 30 minutes, at which time the physician will provide a physical examination and will ask a few questions about your medical condition(s). The doctor will then give you prescriptions (much the same as you would get from your American doctor), which can be taken to the nearest pharmacy to be filled.

Canadian pharmacies work the same way as American pharmacies-prescriptions are turned in and filled while you wait. Be sure to ask the pharmacists any questions you may have about your medications.
 
Some Frequently Asked Questions:

"Will the border guards give me any trouble when I cross the border?"

So far, there have been no reports of any difficulties crossing the border with prescription drugs. The guards are very accustomed to Americans going to Canada to fill their prescriptions.

"Why do I have to see a Canadian doctor? Why can’t I simply bring my prescriptions to a Canadian pharmacy?"

Law requires that prescriptions be written from a Canadian doctor. Prescriptions written from American physicians will not be honored, and law also states that in order to write a prescription, a doctor must perform an exam on the patient.

"I’ve seen commercials claiming that when Americans go to Canada to fill prescriptions, they are helping to deteriorate the Canadian health care system. Is this true?"

The pharmaceutical companies fund these television commercials and newspaper advertisements in an effort to discourage Americans from purchasing their drugs at lower costs in Canada. There is no record of any decline in the Canadian health care system as a result of Americans buying medicine.

"I’ve heard that the drugs aren’t the same in Canada as they are in the US. Is this true?"

The same US companies that manufacture US drugs manufacture the drugs in Canada. There are generic drugs available in Canada that may not be the exact medication as the brand name, but these tend to be the same generics that are available in the US.

"I’ve been told that some drugs aren’t available in Canada. Is this true?"

Yes, there are a few drugs which are not available in Canada. These tend to be very new medicines, however there are drugs used in the US which are simply not available in Canada. Check with the Canadian physician before making the trip.

"If I can only bring a three-month supply of drugs over the border, does that mean I have to keep going back every three months for refills?"

Yes, at this time this is the only way to refill prescriptions.

"Are there certain drugs I cannot bring over the border?"

Yes, certain controlled narcotic substances cannot be purchased in Canada. Check with your Canadian physician for specific details.

"What if I have more questions that were not answered in this packet?"
You may call or email William Fleming at the Central Vermont Council on Aging at (802) 479-0531 or [email protected] if you have additional questions.

*This packet is intended for informational purposes only. We cannot guarantee the success of obtaining prescription drugs in Canada through the use of this information.
 
SANDERS RELEASES REPORT DETAILING FDA COMMISSIONER’S DRUG INDUSTRY TIES
Many of the same commissioners who claim reimportation is unsafe work / worked for drug industry



WASHINGTON - Congressman Bernard Sanders (I-VT) today released a report detailing how at least 7 out of the 11 FDA commissioners who claim prescription drug reimportation legislation is unsafe have strong financial ties to the pharmaceutical and medical equipment industry. Additionally, one of these commissioners who the industry claims opposes the legislation actually testified before Congress against the law that made reimportation illegal. In radio, television and newspaper ads across the country, the pharmaceutical industry is touting letters from 11 current and former FDA commissioners which claim that Sanders’ and Wellstone’s reimportation legislation will pose a safety risk to consumers. The report released today, however, exposes that these are not “objective” positions, as a majority of these commissioners are connected to the drug industry. Reimportation legislation has passed both the House and Senate by overwhelming bipartisan majorities as part of the Agriculture Appropriations Bill.

Recommend
This Page To A Friend



Sanders said, “The pharmaceutical industry is the most powerful special interest in Washington. They not only have the money to hire 300 lobbyists on Capitol Hill, contribute $9 million to both political parties and spend tens of millions on advertising, but they have been also to put a number of former FDA commissioners on their payroll. The story here is not that some former FDA officials oppose our efforts to pass a reimportation bill and substantially lower the price of prescription drugs in this country, but that a cynical “revolving door” policy exists between the FDA and the drug companies. The American people should have deep concerns about a process in which individuals who had the responsibility of regulating an industry end up on working for them after they leave government.”

According to the report, acting FDA commissioners Michael Friedman, Mark Novitch, Arthur Hull Hayes and Jere Goyan are all currently employed by pharmaceutical companies. These same companies have a direct financial stake in whether reimportation legislation passes and prices are brought down, or whether the legislation is defeated in conference committee. One other commissioner, Donald Kennedy, is the President Emeritus of Stanford University, which reaps millions in royalties from profits from various pharmaceuticals. One commissioner, Frank E. Young, testified in 1986 against the ban on reimportation which has allowed drug companies to charge Americans the highest prices for prescription medications in the world.

Even without the new report exposing the commissioners, Sanders said claims that reimportation legislation is unsafe are false because the bill would only allow FDA-safety approved medications into the United States. He pointed out a report released from his office last month that showed the bill’s strong import testing requirements are much like those employed in Western Europe, where reimportation is a common practice and where drug counterfeiting has not been a problem.
 
International Prescription Drug Parity Act (HR 1885 / S 1191)
Reps. Marion Berry, Bernard Sanders, Jo Ann Emerson

HR 1885 was introduced in response to the alarmingly high cost of pharmaceuticals in the United States as compared to Mexico and Canada and other nations.



The bill would allow American distributors and pharmacists to re-import prescription drugs into the United States from Mexico and Canada as long as the drugs meet strict safety standards and are approved by the FDA. Pharmacists and distributors will be able to purchase drugs at lower prices and then pass the huge savings along to American consumers.



Summary | Detailed Status of Bill | Text of Legislation



Prescription Drug Fairness for Seniors Act (HR 664 / S 731)
Reps. Tom Allen, Jim Turner, Henry Waxman

Studies in congressional districts across the nation have shown that drug manufacturers engage in widespread price discrimination. Seniors and others who buy their own prescription drugs are forced to pay twice as much for their drugs as are the drug manufacturers’ most favored customers, such as the federal government and large HMOs. For some prescription drugs, seniors must pay ten times more than favored customers.

The Prescription Drug Fairness for Seniors Act will protect senior citizens from drug price discrimination and make prescription drugs available to Medicare beneficiaries at substantially reduced prices. The legislation achieves these goals by allowing pharmacies that serve Medicare beneficiaries to purchase prescription drugs at the low prices available to the federal government and other favored customers.


Summary | Detailed Status of Bill | Text of Legislation



Health Care Research and Development and Taxpayer Protection Act (HR 626)
Rep. Bernie Sanders

HR 626 was introduced to prevent taxpayers from being charged twice for the same drug by instituting a reasonable pricing clause for the National Institutes of Health.

Currently, taxpayers fund the development of drugs at the NIH, which in turn sells the drug to a pharmaceutical corporation for very little money. Once the drug company has control of the product, they charge an exorbitant amount of money to consumers.
 
Top Bottom